Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Absci Corporation (Nasdaq: ABSI) announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 10th at 12:45 p.m. PT / 3:45 p.m. ET. This presentation will be conducted virtually, and interested individuals can access a live and archived webcast through the company's website.

Absci specializes in drug and target discovery using deep learning AI and synthetic biology, aiming to advance protein therapeutic potential. For more information, visit www.absci.com.

VANCOUVER, Wash., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming 40^th Annual J.P. Morgan Healthcare Conference.

Absci’s management is scheduled to present on Monday, January 10th at 12:45 p.m. Pacific Time / 3:45 p.m. Eastern Time. This presentation time has been updated from a previous announcement and reflects the current schedule. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website via www.absci.com.

About Absci

Absci is the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including those that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com and follow us on social media: Twitter: @Abscibio, LinkedIn: @absci.

Availability of Other Information about Absci

Investors and others should note that we routinely communicate with investors and the public using our website (www.absci.com) and the “Investors” section of our website (investors.absci.com), including without limitation, through the posting of investor presentations, SEC filings, press releases, public conference calls and webcasts on these websites. The information that we post on these websites could be deemed to be material information. As a result, investors, the media, and others interested in Absci are encouraged to review this information on a regular basis. The contents of our website, or any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Investor Contact

investors@absci.com

Media Contact

press@absci.com

 

FAQ

When is Absci Corporation's presentation at the J.P. Morgan Healthcare Conference?

Absci Corporation's presentation is scheduled for January 10th at 12:45 p.m. Pacific Time / 3:45 p.m. Eastern Time.

How can I access Absci Corporation's presentation at the conference?

You can access a live and archived webcast of Absci Corporation's presentation on the 'Investors' section of their website.

What is Absci Corporation known for?

Absci Corporation is known for its drug and target discovery capabilities, utilizing deep learning AI and synthetic biology to enhance therapeutic potential.

What is the stock symbol for Absci Corporation?

The stock symbol for Absci Corporation is ABSI.

Where can I find more information about Absci Corporation?

More information about Absci Corporation can be found on their official website, www.absci.com.